Cargando…

5-Aminolevulinic Acid as a Novel Therapeutic for Inflammatory Bowel Disease

5-Aminolevulinic acid (5-ALA) is a naturally occurring nonprotein amino acid licensed as an optical imaging agent for the treatment of gliomas. In recent years, 5-ALA has been shown to possess anti-inflammatory and immunoregulatory properties through upregulation of heme oxygenase-1 via enhancement...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yadav, Vipul, Mai, Yang, McCoubrey, Laura E., Wada, Yasufumi, Tomioka, Motoyasu, Kawata, Satofumi, Charde, Shrikant, Basit, Abdul W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8160866/ https://www.ncbi.nlm.nih.gov/pubmed/34065300 http://dx.doi.org/10.3390/biomedicines9050578

Ejemplares similares

The use of mechanical bowel preparation in elective colorectal surgery
por: McCoubrey, Alison S
Publicado: (2007)

Harnessing machine learning for development of microbiome therapeutics
por: McCoubrey, Laura E., et al.
Publicado: (2021)

Progestogens Are Metabolized by the Gut Microbiota: Implications for Colonic Drug Delivery
por: Coombes, Zoe, et al.
Publicado: (2020)

Impact of Peptide Structure on Colonic Stability and Tissue Permeability
por: Taherali, Farhan, et al.
Publicado: (2023)

Ileocolonic-Targeted JAK Inhibitor: A Safer and More Effective Treatment for Inflammatory Bowel Disease
por: Yadav, Vipul, et al.
Publicado: (2022)

Machine Learning Uncovers Adverse Drug Effects on Intestinal Bacteria
por: McCoubrey, Laura E., et al.
Publicado: (2021)

Machine Learning Predicts Drug Metabolism and Bioaccumulation by Intestinal Microbiota
por: McCoubrey, Laura E., et al.
Publicado: (2021)

La tradición en la pintura norteamericana
por: McCoubrey, John W.
Publicado: (1967)

American art, 1700-1960 : sources and documents
por: McCoubrey, John W.
Publicado: (1965)

Therapeutic effects of topical 5-aminolevulinic acid photodynamic therapy
por: Hu, Yin-E, et al.
Publicado: (2016)

Is the “red flag” referral pathway effective in diagnosing colorectal carcinoma?
por: McCoubrey, Alison, et al.
Publicado: (2012)

Feasibility of surveillance of ICU-associated infections in Scotland
por: Booth, M, et al.
Publicado: (2006)

Identification of Latent Safety Threats in an Interprofessional Training Involving On-Site Simulation in a Birthing Unit in Response to the COVID-19 Pandemic
por: De Simone, Avina, et al.
Publicado: (2022)

Surveillance of ICU-associated infections
por: MacKirdy, F, et al.
Publicado: (2006)

OA21 Ankylosing Spondylitis management with Secukinumab but related Inflammatory bowel disease phenomenon
por: Iqbal, Sultan, et al.
Publicado: (2022)

The Effect of 5-Aminolevulinic Acid on Cytochrome P450-Mediated Prodrug Activation
por: Miura, Mai, et al.
Publicado: (2015)

Derivatives of 5-Aminolevulinic Acid for Photodynamic Therapy
por: Donnelly, Ryan F., et al.
Publicado: (2007)

Inflammatory cell death induced by 5-aminolevulinic acid-photodynamic therapy initiates anticancer immunity
por: Wang, Lingyan, et al.
Publicado: (2023)

Therapeutic Potential of Amino Acids in Inflammatory Bowel Disease
por: Liu, Yulan, et al.
Publicado: (2017)

Homology Modeling of Human γ-Butyric Acid Transporters and the Binding of Pro-Drugs 5-Aminolevulinic Acid and Methyl Aminolevulinic Acid Used in Photodynamic Therapy
por: Baglo, Yan, et al.
Publicado: (2013)

Prenatal lead exposure, delta-aminolevulinic acid, and schizophrenia.
por: Opler, Mark G A, et al.
Publicado: (2004)

5-Aminolevulinic acid improves chicken sperm motility
por: Taniguchi, Shin, et al.
Publicado: (2021)

Effects of 5-aminolevulinic acid-mediated sonodynamic therapy on macrophages
por: Cheng, Jiali, et al.
Publicado: (2013)

Aminolevulinic Acid (ALA) as a Prodrug in Photodynamic Therapy of Cancer
por: Wachowska, Małgorzata, et al.
Publicado: (2011)

5-Aminolevulinic acid fermentation using engineered Saccharomyces cerevisiae
por: Hara, Kiyotaka Y., et al.
Publicado: (2019)

Primary central nervous system lymphoma and 5-aminolevulinic acid
por: Ferrer, Pierre, et al.
Publicado: (2020)

Structural basis for dysregulation of aminolevulinic acid synthase in human disease
por: Taylor, Jessica L., et al.
Publicado: (2022)

Natural 5-Aminolevulinic Acid: Sources, Biosynthesis, Detection and Applications
por: Jiang, Meiru, et al.
Publicado: (2022)

Sodium Ferrous Citrate and 5-Aminolevulinic Acid Exert a Therapeutic Effect on Endotoxin-Induced Uveitis in Rats
por: Otaka, Yuya, et al.
Publicado: (2023)

Bile acids and their receptors: Potential therapeutic targets in inflammatory bowel disease
por: Long, Xiong-Quan, et al.
Publicado: (2023)

Comparative Study of Photodynamic Therapy with Topical Methyl Aminolevulinate versus 5-Aminolevulinic Acid for Facial Actinic Keratosis with Long-Term Follow-Up
por: Ko, Dong-Yeob, et al.
Publicado: (2014)

The future of robotic surgery for inflammatory bowel diseases
por: Gul, Fahad, et al.
Publicado: (2022)

Telemedicine: A promising future for inflammatory bowel disease management
por: Fazal, Faizan, et al.
Publicado: (2022)

Photodynamic diagnosis of breast tumours after oral application of aminolevulinic acid
por: Ladner, D P, et al.
Publicado: (2001)

Prenatal Exposure to Lead, δ-Aminolevulinic Acid, and Schizophrenia: Further Evidence
por: Opler, Mark G.A., et al.
Publicado: (2008)

δ-Aminolevulinic Acid Dehydratase Polymorphism and Risk of Brain Tumors in Adults
por: Rajaraman, Preetha, et al.
Publicado: (2005)

Regulation of Delta-Aminolevulinic Acid Dehydratase by Krüppel-Like Factor 1
por: Desgardin, Aurelie D., et al.
Publicado: (2012)

δ-Aminolevulinic acid cytotoxic effects on human hepatocarcinoma cell lines
por: De Siervi, Adriana, et al.
Publicado: (2002)

5-Aminolevulinic Acid Fluorescence Discriminates the Histological Grade of Extraventricular Neurocytoma
por: Song, Sang Woo, et al.
Publicado: (2013)

In vitro evaluation of 5-aminolevulinic acid (ALA) loaded PLGA nanoparticles
por: Shi, Lei, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_u8pjf6m6r25ri3fjbm25ggo7ta